...BRCA2 (BRCA1/2) are related to an increased lifetime risk of developing breast and ovarian cancer. Although risk-reducin...
...BRCA2 (BRCA1/2) mutations. We sought to determine if clinically identified mutation carriers differed in clinical charac...
...BRCA2) are probably responsible for only 40% of the excess familial ovarian cancer risks, suggesting that other suscepti...
...BRCA2 and the recombination enzyme RAD51; it makes use of a screening pipeline of biophysical techniques that we expect ...
...BRCA2 carriers and 37 % in non-carriers (P = 0.001). Median follow-up was 2.8 years. BRCA non-carriers and BRCA2 carrier...
...BRCA2 that impair homologous recombination. However, since many tumors, including prostate cancer (PCa) rarely have on s...
Risk-reducing bilateral salpingo-oophorectomy (RRBSO) and risk-reducing mastectomy are widely used for BRCA1 and BRCA2 m...
...BRCA2 and 26 non-BRCA1/2) and 15 sporadic tumours in combination with supervised and unsupervised analysis was used to d...
To analyze the baseline clinicopathologic characteristics of prostate tumors with germline BRCA1 and BRCA2 (BRCA1/2) mut...
...BRCA2 gene.,We followed 4456 women with a BRCA1 or a BRCA2 mutation for incident cases of endometrial cancer. The incide...
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话: 0531-88819269